Brief: Monopar Therapeutics Reports First Quarter 2022 Financial Results
12/05/2022 13:31
May 12 (Reuters) - Monopar Therapeutics Inc MNPR.O :
* MONOPAR THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND RECENT PROGRAM DEVELOPMENTS
* QTRLY NET LOSS PER SHARE$0.19
* Q1 EARNINGS PER SHARE VIEW $-0.22 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX1pYFz5
Further company coverage: MNPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Monopar Therapeutics
See all newsBrief: Monopar Appoints Jeffrey D. Kent, M.D., As Executive Vice President, Head Of Medical Affairs Announces Two Alxn1840 Presentations At Aasld – The Liver Meeting 2026
U.S. RESEARCH ROUNDUP-Airbnb, Five Below, Silgan Holdings
Monopar Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Monopar Therapeutics Inc. expected to post a loss of 62 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla